Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Whole-body MRI-guided Intensity Modulated Radiation Therapy Combined With Systemic Chemotherapy Followed by High-Dose Chemotherapy With Busulfan, Melphalan and Topotecan and Stem Cell Rescue in Patients With Poor Risk Ewing's Sarcoma

NCT01795430 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT01795430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01795430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Whole-body MRI-guided Intensity Modulated Radiation Therapy Combined With Systemic Chemotherapy Followed by High-Dose Chemotherapy With Busulfan, Melphalan and Topotecan and Stem Cell Rescue in Patients With Poor Risk Ewing's Sarcoma
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
July 31, 2013
Completion date
Not reported
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult supratentorial primitive neuroectodermal tumor (pnet), ewing sarcoma of bone, extraosseous ewing sarcoma, metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor, recurrent childhood supratentorial primitive neuroectodermal tumor, recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor, untreated childhood supratentorial primitive neuroectodermal tumor